vimarsana.com
Home
Live Updates
Enzolytics, Inc.: Enzolytics Announces the Discovery of Cons
Enzolytics, Inc.: Enzolytics Announces the Discovery of Cons
Enzolytics, Inc.: Enzolytics Announces the Discovery of Conserved, Immutable Target Sites on HTLV-1 and Plans To Commence Production of Monoclonal Antibodies Targeting These Sites
COLLEGE STATION, TX / ACCESSWIRE / May 26, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (the "Company") today announced it has identified conserved, expectedly immutable sites on the HTLV-1 virus against which
Related Keywords
United States ,
Texas ,
Kostenloser Wertpapierhandel ,
Tom Nelson ,
Charles Cotropia ,
While Enzolytics Inc ,
University Institute For Preclinical ,
Investor Relations Company Contact ,
Texasam University ,
Drug Administration ,
Research Center ,
Enzolytics Inc ,
Institute For Preclinical ,
Artificial Intelligence ,
Inactivated Pepsin Fraction ,
Harbor Statement ,
Relations Company Contact ,
Enzolytics ,
Nnounces ,
Discovery ,
Conserved ,
Immutable ,
Target ,
Sites ,
Stlv ,
Plans ,
Ommence ,
Production ,
Monoclonal ,
Antibodies ,
Targeting ,
These ,
ஒன்றுபட்டது மாநிலங்களில் ,
டெக்சாஸ் ,
டோம் நெல்சன் ,
ஆராய்ச்சி மையம் ,
செயற்கை உளவுத்துறை ,
துறைமுகம் அறிக்கை ,
இதெச் ,